Philips unveils results from clinical trials evaluating Stellarex DCB - Compelo

Philips unveils results from clinical trials evaluating Stellarex DCB  Compelo

Philips, has announced the three-year results from the ILLUMENATE Pivotal trial and the ILLUMENATE EU RCT clinical trial evaluating Stellarex DCB.



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more